TScan Therapeutics Inc. (TCRX)
Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 77
-0.03
-3.2368%
$
54.95M Market Cap
- P/E Ratio
- Div Yield
902,032 Volume
-1.04 Eps
$ 0.79
Previous Close 
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 2.78M | $16.16M | $2.59M | -$13.57M | -83.99% |
 Kyle P. Smith NewEdge Wealth LLC | 91,463 | $141,767.65 | $84,694.74 | -$57,072.91 | -40.26% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $2 | $1.85 | -$0.15 | -7.5% |
